Abstract
In a review of adverse events associated with childhood vaccines, the Vaccine Safety Committee of the Institute of Medicine (IOM) in 1993 concluded that a causal relationship exists between live-virus measles-mumps-rubella (MMR) vaccination and thrombocytopenia.1 This finding was based on case reports of temporally associated onset of acute thrombocytopenia purpura and MMR vaccination,2,3 population-based surveillance of adverse vaccine reactions in Sweden4 and Finland,5 and demonstrated decreases in platelet concentrations after measles vaccination with the Edmonston B strain.6 The IOM committee also noted that children with prior histories of thrombocytopenia may be at an increased risk of recurrence after MMR vaccination.
- Received May 19, 1995.
- Accepted August 3, 1995.
- Copyright © 1996 by the American Academy of Pediatrics
Individual Login
Institutional Login
You may be able to gain access using your login credentials for your institution. Contact your librarian or administrator if you do not have a username and password.
Log in through your institution
Pay Per Article - You may access this article (from the computer you are currently using) for 2 days for US$25.00
Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.
In this issue
Jump to section
Related Articles
Cited By...
- Recurrent immune thrombocytopenia following different vaccines
- Is MMR immunisation safe in chronic Idiopathic thrombocytopenic purpura?
- Idiopathic thrombocytopenic purpura and the second dose of MMR
- Short report: Idiopathic thrombocytopenic purpura and MMR vaccine
- Chimeric Plant Virus Particles Administered Nasally or Orally Induce Systemic and Mucosal Immune Responses in Mice